Skip to content

Management of twakagata vata (xeroderma) with Ashwagandhadya Ghrita and Ksheer Bala Tail thereby assessing Ruksh guna.

Assessment and Validation of Ruksha Guna in Purview of Twakagata Vata (Xeroderma) and its Management with Ashwagandhadya Ghrita and Ksheer Bala Tail

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/09/028000
Enrollment
45
Registered
2020-09-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L989- Disorder of the skin and subcutaneous tissue, unspecified

Interventions

Intervention1: Ksheer bala tail for external application: 15 patients will be given Ksheer bala tail (as per requirement) for external application for 45 days Control Intervention1: Ashwagandhadya gh

Sponsors

RGGPG Ayurvedic College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Individuals willing and able to participate in the trial. 2. Patients irrespective of age, sex, religion, occupation and chronicity will be selected for the study. 3. Patients with clinical signs of twakagata vata as per ayurvedic classics- a. Twakarukshta b. Sfutita c. Suptata d. Krisha e. Krishanta f. Toda g. Taanyta h. Raag i. Parvruk

Exclusion criteria

Exclusion criteria: 1. Individuals not willing to participate in the trial. 2. Patients suffering from other systemic or metabolic disorders like dyslipidemia, hypertension and hepatic disorders.

Design outcomes

Primary

MeasureTime frame
Overall improvement which will be shown by the patients in signs and symptoms according to subjective and objective criteria.Timepoint: 45 days

Secondary

MeasureTime frame
general feeling of well beingTimepoint: 45 days

Countries

India

Contacts

Public ContactDr Vividha Mahant

RGGPG Ayurvedic College and Hospital

drsharmanaresh01@gmail.com9418017616

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026